Suomen Solubiologit ry

Doctoral Researcher in Radiopharmaceutical Chemistry – Helsinki, Finland

1.9.2026 | Avoimet työpaikat

https://duunitori.fi/tyopaikat/tyo/doctoral-researcher-in-radiopharmaceutical-chemistry-shsel-20530635?utm_source=loimu&utm_medium=site

Apply by latest 30th of September, 2026

University of Helsinki is seeking a Doctoral Researcher in Radiopharmaceutical Chemistry to join the TRIM research group at the Department of Chemistry, supervised by Associate Professor Mirkka Sarparanta.

The Research Council of Finland-funded PhD project focuses on developing alpha-emitting radioligands for treating multi-organ cancer metastases. The research involves organic synthesis, purification and characterization of radiolabeling precursors, radiolabeling synthesis development, and characterization of radiolabeled compounds. Biological evaluation will include in vitro cell models and in vivo mouse tumor models, with PET and SPECT imaging and biodistribution studies.

Applicants should hold an MSc or equivalent degree in Chemistry, Radiochemistry, Pharmacy, Biochemistry, or a related field. Previous laboratory experience, particularly in organic synthesis and compound characterization, is highly desirable. Experience with radioactive materials or research animals is advantageous.

The role requires independent research skills, strong motivation for multidisciplinary research, good English communication skills, and willingness to travel to collaborating laboratories in Sweden and Poland. The position is approximately 3.5 years, with a starting salary of €2,600–2,800/month.

Target Discovery Lead, Cancer Genomics – Taylor Strategy Partners, Turku

3.8.2026 | Avoimet työpaikat

https://duunitori.fi/tyopaikat/tyo/target-discovery-lead-cancer-genomics-scsom-19902349?utm_source=loimu&utm_medium=site

Job description

We are seeking an accomplished Target Discovery Lead to join our client’s Cancer Genomics Research Team. The Target Discovery Lead drives innovation in cancer genomics by identifying and validating novel therapeutic targets. This role combines strategic thinking, scientific leadership, and cross-functional collaboration to advance high-impact ideas through the discovery pipeline. The ideal candidate will have a strong track record in target identification and validation, preferably within the small molecule space.

Key Responsibilities

Scientific Strategy & Innovation

Monitor emerging trends and breakthroughs in cancer genomics to inspire new target concepts.
Lead ideation sessions and foster a culture of creativity and scientific rigor in target discovery.

Target Identification & Prioritisation

Design and implement strategies for identifying high-potential therapeutic targets in collaboration with bioinformatics and translational research teams.
Evaluate and prioritise target ideas based on biological relevance, feasibility, and clinical impact.

Validation & Advancement

Oversee experimental validation of selected targets, ensuring robust scientific evidence. Develop and conduct complex assays. Analyse and interpret experimental data, synthesise insights, and communicate results effectively in internal reviews and external presentations.
Define clear advancement criteria and decision-making frameworks to progress targets through the pipeline.

Leadership & Accountability

Act as the primary owner for target ideation goals, ensuring timely delivery and alignment with organisational strategy.
Collaborate cross-functionally internally and externally to integrate insights from genomics, bioinformatics, and clinical research.
Initiate and manage strategic collaborations with CROs, academic institutions, and industry partners to accelerate target discovery and validation.
You will work closely with a multidisciplinary team to discover and validate novel cancer targets and help develop first- or best-in-class targets from concept to clinical candidate. This is a unique opportunity to contribute to cutting-edge cancer therapies that can make a real difference for patients.

What We Offer

A chance to work with experienced scientists in a dynamic R&D environment.
A supportive workplace with opportunities for growth.
The opportunity to contribute to innovative therapies that improve patients’ lives.
A culture of friendliness, respect, mutual appreciation, and diversity, creating a safe environment to strive for excellence.
Career paths and development opportunities that support innovation and impact on quality of life.

Key Qualifications

Ph.D. in Molecular Biology, Cancer Genomics, Genetics, or related field.
Postdoctoral industry experience in oncology research, target discovery, or drug development.
Proven track record in target identification and validation within cancer biology.
Strong understanding of genomics, bioinformatics, and translational research.
Demonstrated ability to lead teams and drive projects to completion.
Excellent communication and strategic thinking skills.
Experience with CRISPR-based functional genomics and gene-editing technologies.
Proficiency in multi-omics data analysis (genomics, transcriptomics, proteomics), with experience in flow cytometry, advanced microscopy techniques.

Preferred Skills

Familiarity with computational biology tools and pipelines for target discovery.
Knowledge of tumor biology and resistance mechanisms.
Strong ability to interpret large-scale datasets and integrate insights into experimental design.
Prior experience in pharma or biotech environments with drug discovery exposure.

TSP Talent Solutions and our customers are affirmative action/equal opportunity employers (Minorities/Females/Veterans/Disabled)

Target Discovery Lead, Cancer Genomics – Turku

25.4.2026 | Avoimet työpaikat

https://duunitori.fi/tyopaikat/tyo/target-discovery-lead-cancer-genomics-scsom-19902349

Job description

Key Responsibilities

Scientific Strategy & Innovation

Monitor emerging trends and breakthroughs in cancer genomics to inspire new target concepts.
Lead ideation sessions and foster a culture of creativity and scientific rigor in target discovery.

Target Identification & Prioritisation

Design and implement strategies for identifying high-potential therapeutic targets in collaboration with bioinformatics and translational research teams.
Evaluate and prioritise target ideas based on biological relevance, feasibility, and clinical impact.

Validation & Advancement

Oversee experimental validation of selected targets, ensuring robust scientific evidence. Develop and conduct complex assays. Analyse and interpret experimental data, synthesise insights, and communicate results effectively in internal reviews and external presentations.
Define clear advancement criteria and decision-making frameworks to progress targets through the pipeline.

Leadership & Accountability

Act as the primary owner for target ideation goals, ensuring timely delivery and alignment with organisational strategy.
Collaborate cross-functionally internally and externally to integrate insights from genomics, bioinformatics, and clinical research.
Initiate and manage strategic collaborations with CROs, academic institutions, and industry partners to accelerate target discovery and validation.
You will work closely with a multidisciplinary team to discover and validate novel cancer targets and help develop first- or best-in-class targets from concept to clinical candidate. This is a unique opportunity to contribute to cutting-edge cancer therapies that can make a real difference for patients.

What We Offer

A chance to work with experienced scientists in a dynamic R&D environment.
A supportive workplace with opportunities for growth.
The opportunity to contribute to innovative therapies that improve patients’ lives.
A culture of friendliness, respect, mutual appreciation, and diversity, creating a safe environment to strive for excellence.
Career paths and development opportunities that support innovation and impact on quality of life.

Key Qualifications

Ph.D. in Molecular Biology, Cancer Genomics, Genetics, or related field.
Postdoctoral industry experience in oncology research, target discovery, or drug development.
Proven track record in target identification and validation within cancer biology.
Strong understanding of genomics, bioinformatics, and translational research.
Demonstrated ability to lead teams and drive projects to completion.
Excellent communication and strategic thinking skills.
Experience with CRISPR-based functional genomics and gene-editing technologies.
Proficiency in multi-omics data analysis (genomics, transcriptomics, proteomics), with experience in flow cytometry, advanced microscopy techniques.

Preferred Skills

Familiarity with computational biology tools and pipelines for target discovery.
Knowledge of tumor biology and resistance mechanisms.
Strong ability to interpret large-scale datasets and integrate insights into experimental design.
Prior experience in pharma or biotech environments with drug discovery exposure.

TSP Talent Solutions and our customers are affirmative action/equal opportunity employers (Minorities/Females/Veterans/Disabled)

Senior Scientist, Target Discovery, ADC – Orion, Turku

5.11.2025 | Avoimet työpaikat

Apply latest by 9.11.

https://duunitori.fi/tyopaikat/tyo/senior-scientist-target-discovery-adc-sosri-19709899?utm_source=loimu&utm_medium=site

Job description

About the Role

Orion Pharma is making strategic investments in challenging R&D areas where our expertise can drive breakthroughs-particularly in cancer therapies. As part of this commitment, we are enhancing our oncology research capabilities by establishing dedicated Target Discovery teams within each of our oncology research units: Immuno-Oncology, Antibody Drug Conjugates (ADC), and Cancer Genomics.

We are looking for a motivated and skilled Senior Scientist to join Antibody-Drug Conjugates (ADC) Target Discovery Team. The ideal candidate has strong experience in preclinical cancer research and a solid background in cell and molecular cancer biology, with exposure to bioinformatics.

Key Responsibilities

Design and execute strategies for identifying novel ADC targets using data-driven and lab-based approaches.
Run ADC targets validation
Conduct and/or coordinate experiments to assess ADC potency and safety.
Provide expert guidance in cancer biology to project teams.
Collaborate with internal teams (bioinformatics, chemistry, biology, pharmacology, clinical) to solve scientific challenges.
Propose and manage research activities with strategic partners, CROs, and academic collaborators.
Maintain detailed lab records and documentation.
Analyse experimental data and present findings in meetings.

You will work closely with a multidisciplinary team to discover and validate novel cancer targets and help develop first- or best-in-class ADCs from concept to clinical candidate. This is a unique opportunity to contribute to cutting-edge cancer therapies that can make a real difference for patients.

You will be located in Turku, Finland, and will report to the ADC Target Discovery Lead. This is a full-time, permanent and on-site position. Orion Pharma will support relocation to Finland.

What We Offer

A chance to work with experienced scientists across Orion’s R&D.

A dynamic and supportive work environment with opportunities for growth.

The opportunity to contribute to innovative therapies that improve patients’ lives.

At Orion Pharma, your work creates true impact and well-being for our customers, patients and society at large. Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can strive for excellence. We offer a wealth of career paths and development opportunities that support the development of innovative solutions and improving the quality of life.

Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/ .

Our expectations

Essential competences, education and way of working :

MS, or PhD in Biological Sciences, Biochemistry or closely related field with typically 10+ (MS) or 4+ (PhD) years of postdoc or industry related experience.
Strong understanding and experience of cancer biology, cell and molecular biology, and biochemistry.
Practical experience with bioinformatics and omics data (transcriptomics, proteomics, spatial data) and analysis (e.g. online tools, R or Python).
Hands-on experience with lab techniques: cell surface proteins labelling and analysis, flow cytometry, microscopy, cytotoxicity assays, qPCR, western blotting, and ELISA.
Experience with 2D and 3D cell culture models.
Demonstrated ability to work independently and lead research activities.
Strong interest in adopting new technologies and methods.
Excellent problem-solving, communication, and organizational skills.

How to apply and additional information

Please send your application with the latest CV, cover letter, and salary request in English by 9th of November 2025. Please note that we will start reviewing applications during the application period.

For additional details, do not hesitate to contact Antti Arjonen, ADC Target Discovery Lead, +358 40 721 9109 on any of the following times (Finnish Time): 5th Nov between 9am-4pm and 6th Nov between 9am-1pm (EET).

#LI-ORION

Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.

Unit description

Orion Pharma’s pharmaceutical innovations are created within its R&D organization. We employ around 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in New York, NY, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.

Target Discovery Team is part of the Antibody-Drug Conjugates (ADC) Research Group, one of three scientific units within Oncology Research, a division of Orion’s R&D Organization. Our team is dedicated to the discovery and validation of therapeutic ADC targets, leveraging omics technologies alongside a broad array of biophysical, biochemical, molecular, cellular, and in vivo methods. We strive to develop cutting-edge ADC therapies with the potential to transform the lives of cancer patients.

About Us

Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.

We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.

Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.

We offer careers with a clear purpose: empowering people to live their lives to the fullest.

Postdoctoral Research Fellow (Translational Leukemia Research) – University of Tampere

31.10.2024 | Avoimet työpaikat

https://duunitori.fi/tyopaikat/tyo/postdoctoral-research-fellow-translational-leukemia-research-tutkijatohtori-translationaalinen-stsam-18681352?utm_source=loimu&utm_medium=site

Apply latest by 4.11.

Tampere University and Tampere University of Applied Sciences create a unique environment for multidisciplinary, inspirational and high-impact research and education. Our university community has its competitive edges in technology, health and society. www.tuni.fi/en .

The Hemato-oncology Research Group (HemoRES) at Faculty of Medicine and Health Technologyis looking for a Postdoctoral Research Fellow specializing in translational leukemia research. The research group works under the Tampere Center for Child, Adolescent and Maternal Health Research (TamCAM). The position is full-time and will be filled for a fixed-term period of three years.

The Hemato-oncology research group studies the molecular mechanisms underlying childhood acute lymphoblastic leukemia (ALL), aiming to develop novel, mechanism-based targeted therapies. Our approach combines a variety of genomic and molecular analyses, drug screening, patient samples, and disease modeling using both cellular and animal systems, including zebrafish.

The Faculty of Medicine and Health Technology (MET) is committed to high quality research and education in the fields of biomedical engineering, biotechnology, medicine, and health technology. We conduct basic, applied, clinical, and translational research in collaboration with Tampere University Hospital (TAYS). Our existing research areas in health research include biomedical engineering fields from biomaterials and microtechnologies to health data science, cell and molecular biology, with applications in areas such as cancer, cardiovascular and celiac diseases, immunology, and ophthalmology.

Job description

We are looking for a talented and motivated postdoctoral researcher to join a project led by Prof. Olli Lohi. The project, funded by the Jane & Aatos Erkko Foundation, focuses on developing targeted therapies for T-cell acute lymphoblastic leukemia (T-ALL). Our research aims to identify novel and effective combination treatments for T-ALL, enhance immunotherapies, and investigate the mechanisms of drug resistance. The work involves the use of cell lines, patient samples, zebrafish models, and a variety of cellular, molecular, and genome-wide assays.

Requirements

We are seeking a versatile and independent researcher with experience and a proven track record-such as published work or a thesis-in a wide range of cellular and molecular biology techniques, including cell culture, drug testing, CRISPR/Cas9 gene editing, and data analysis (e.g., NGS data, R software). Prior experience with leukemia research or zebrafish experimentation would be appreciated.

Applicable doctoral degree in the field, e.g. Molecular and Cellular Biology, Immunology, Cancer Biology, or Genomics
High motivation and a strong research orientation
The ability to work independently, and stay current with relevant literature
Strong interpersonal and networking skills, along with a willingness to mentor junior researchers
Fluency in spoken and written English.

Tampere University is a unique, multidisciplinary, and boldly forward-looking community. Our values are openness, diversity, responsibility, courage, critical thinking, and learner-centredness. We hope that you can embrace these values and promote them in your work.

We offer

The position will be filled for a fixed-term period of three years, starting on 1 January 2025 or as mutually agreed. A trial period of six months applies to all our new employees.

The salary will be based on both the job requirements and the employee’s personal performance in accordance with the Finnish University Salary System. The position of a Postdoctoral Researcher is placed on the job demands levels 5-6 (teaching and research staff). A typical starting salary of Postdoctoral Researcher is around 3500-3800 EUR/month.

We offer a world-class research environment in internationally recognized research groups. We have strong collaborative networks and offer great opportunities for researchers to develop their careers in an international setting. We offer you the opportunity to join our dynamic and innovative international community.

As a member of staff at Tampere University, you will enjoy a range of competitive benefits, such as occupational health care services, flexible work schedule, versatile research infrastructure, modern teaching facilities and a safe and inviting campus area as well as a personal fund to spend on sports and cultural activities in your free time. Please read more about working at Tampere University. You can also find more information about us and working and living Tampere by watching our video: Tampere Higher Education Community – our academic playground.

Finland is among the most stable, free and safe countries in the world, based on prominent ratings by various agencies. Tampere is the largest inland city of Finland, and the city is counted among the major academic hubs in the Nordic countries. Tampere region is the most rapidly growing urban area in Finland and home to a vibrant knowledge-intensive entrepreneurial community. The city is an industrial powerhouse that enjoys a rich cultural scene and a reputation as a centre of Finland’s information society. Tampere is also surrounded by vivid nature with forests and lakes, providing countless opportunities for easy-to-access outdoor adventures and refreshment throughout the year.

Ajankohtaista